1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Target Group Inc.

Target Group Inc.

CBDY
Target Group Inc.US flagOther OTC
0.00
USD
- -
- -
925,539.00Market Cap
Target Group Inc.
CBDY
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
0.22
0.01
- -
- -
- -
- -
- -
0.01
0.01
- -
0.01
Revenue per Share
- -
-0.2
-34.19
-341.27
-85.83
-0.72
-0.04
-0.03
-0.01
- -
-0.01
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.04
-3.56
-23.9
-20.45
-0.11
-0.05
-0.02
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
-34.18
-385.6
-199.59
-2.98
-0.2
-0.05
-0.05
-0.04
-0.05
-0.05
-0.05
- -
-0.05
Book Value per Share
- -
- -
-26.57
-135.11
-71.66
-0.85
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
- -
-0.01
Tangible Book Value per Share
- -
- -
- -
- -
- -
2
46
410
567
595
617
617
617
- -
617
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
7
4
3
Sales/Revenue/Turnover
- -
- -
- -
- -
-27,394
-5,085.85
-515,845.25
- -
-5,238.32
- -
- -
-11.59
16.94
-5.71
-20.26
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
Depreciation Expense
- -
- -
- -
-3
-2
-2
-2
-10
-7
- -
-5
- -
- -
-1
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
-39,619.26
-11,291.19
-722,563.12
- -
-23,579.57
- -
- -
-8.7
2.43
-35.03
-53.63
Profit Margin (%)
- -
- -
- -
-1
-2
-2
-3
-5
-4
-3
-6
-11
-10
-11
-11
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
2
2
1
1
1
1
1
LT Debt
- -
- -
- -
-1
-2
-2
3
4
-4
-2
-7
-7
-7
-8
-9
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-5.1
- -
- -
-4.42
- -
- -
Return on Capital (%)
- -
-209.53
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
617
617
617
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2
2
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
1
2
2
Total Current Liabilities
13
13
14
Payables & Accruals
12
13
13
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-17.18%
37.89%
23.9%
Free Cash Flow
-66.53%
-369.3%
-143.81%
Net Income, GAAP
-266.74%
-609.97%
-947.13%
Sales/Revenue/Turnover
- -
- -
-41.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
2
1
2
7
2025
1
1
- -
1
4
2026
1
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Greenfern Industries Limited (GFI.NZ)
Yuhan Corporation (000100.KS)
Cresco Labs Inc. (CL.CN)
Verano Holdings Corp. (VRNOF)
NxGen Brands Inc. (NXGB)
Voyageur Pharmaceuticals Ltd. (VYYRF)
Business
Target Group Inc. (OTCQB:CBDY) cultivates, processes, and distributes curated cannabis and hemp products for the medical and adult-use recreational markets in Canada and the United States; its core offerings include cannabis flower and extract pods for vaporizer use, cannabis pre-rolls, K-cup infused coffee and tea pods, infused cannabis beverages and edibles, infused topical products, and CBD wellness products; the company also provides Wisp, a single-use pre-measured pod and vaporizer system for vaporizing natural herbs including cannabis. Founded in 2013 and headquartered at 20 Hempstead Drive in Hamilton, Ontario, Canada, Target Group operates as a vertically integrated seed-to-sale consumer packaged goods company through its subsidiary Canary Rx Inc., a licensed producer under the Cannabis Act with a 44,000 square foot facility in Norfolk County, Ontario; it maintains an international network of manufacturing, distribution, production, and sales operations while curating an exclusive portfolio of cannabis brands via selective partnerships and strategic acquisitions. Recent developments include reporting net income of $160,504 for fiscal year 2024 ended December 31, up from a prior-year loss, with revenue of $6.59 million primarily from cannabis product sales; the company sustains its strategic partnership with Serious Seeds B.V. for production and distribution of award-winning cannabis seeds and genetics, alongside a multi-year agreement with Cannavolve Inc. for selling recreational cannabis-derived products across Canada and a collaboration with cGreen Inc. for manufacturing and distributing the THC antidote True Focus in the United States, Europe, and the Caribbean.